(thirdQuint)Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS).

 A prospective, single-arm, multi-center study, enrolling symptomatic patients with chronic functional tricuspid regurgitation.

 The study will include up to 60 subjects from up to 15 sites in Europe and the United States.

 Follow-up evaluations will be conducted through 5 years post implantation.

.

 Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)@highlight

The purpose of this study is to assess the safety and performance of the Trialign System for the treatment of symptomatic chronic functional tricuspid regurgitation (FTR) in patients with a minimum of moderate tricuspid regurgitation.

 The procedure will be performed with the PTVAS device using a non-surgical percutaneous approach to tricuspid valve repair in patients who have FTR with a minimum of moderate tricuspid regurgitation.

